Since we can only speculate on the impact of those findings and those could also be artificial due to the small clinical cohort, further studies are required to investigate the role of SGLT-2 inhibitors and cardiovascular risk factors on HF worsening. The gene discussed is SLC5A2; the disease is hydrops fetalis.